Cost-effectiveness of laparoscopic fundoplication versus continued medical management for the treatment of gastro-oesophageal reflux disease based on long-term follow-up of the REFLUX trial

British Journal of Surgery

Volumn 100, Issue 9, 2013, Pages 1205-1213

  Faria, R ^a   Bojke, L ^a   Epstein, D ^a,b   Corbacho, B ^a   Sculpher, M ^a  

^a UNIVERSITY OF YORK   (United Kingdom)

^b UNIVERSITY OF GRANADA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMBULATORY SURGERY; ARTICLE; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST BENEFIT ANALYSIS; ECONOMICS; GASTROESOPHAGEAL REFLUX; HUMAN; LAPAROSCOPY; LENGTH OF STAY; METHODOLOGY; MULTICENTER STUDY; QUALITY ADJUSTED LIFE YEAR; RANDOMIZED CONTROLLED TRIAL; STOMACH FUNDOPLICATION; TREATMENT OUTCOME;

AMBULATORY SURGICAL PROCEDURES; COST-BENEFIT ANALYSIS; FUNDOPLICATION; GASTROESOPHAGEAL REFLUX; HUMANS; LAPAROSCOPY; LENGTH OF STAY; QUALITY-ADJUSTED LIFE YEARS; TREATMENT OUTCOME;

EID: 84880132728     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.9190     Document Type: Article

References (35)

1. Dent J, El-Serag HB, Wallander MA, Johansson S,. Epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut 2005; 54: 710-712.
2. Quigley EM, Hungin AP,. Review article: quality-of-life issues in gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2005; 22: 41-47.
3. Pisegna J, Holtmann G, Howden CW, Katelaris PH, Sharma P, Spechler S, et al. Review article: oesophageal complications and consequences of persistent gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2004; 20 (Suppl 9): 47-56.
4. Ali T, Roberts DN, Tierney WM,. Long-term safety concerns with proton pump inhibitors. Am J Med 2009; 122: 896-903.
5. Davis CS, Baldea A, Johns JR, Joehl RJ, Fisichella PM,. The evolution and long-term results of laparoscopic antireflux surgery for the treatment of gastroesophageal reflux disease. JSLS 2010; 14: 332.
6. Arguedas MR, Heudebert GR, Klapow JC, Centor RM, Eloubeidi M, Wilcox CM, et al.; VA Cooperative Study Group. Re-examination of the cost-effectiveness of surgical versus medical therapy in patients with gastroesophageal reflux disease: the value of long-term data collection. Am J Gastroenterol 2004; 99: 1023-1028.
7. Bojke L, Hornby E, Sculpher M,; REFLUX Trial Team. A comparison of the cost effectiveness of pharmacotherapy or surgery (laparoscopic fundoplication) in the treatment of GORD. Pharmacoeconomics 2007; 25: 829-841.
8. Comay D, Adam V, da Silveira EB, Kennedy W, Mayrand S, Barkun AN,. The Stretta procedure versus proton pump inhibitors and laparoscopic Nissen fundoplication in the management of gastroesophageal reflux disease: a cost-effectiveness analysis. Can J Gastroenterol 2008; 22: 552-558.
9. Cookson R, Flood C, Koo B, Mahon D, Rhodes M,. Short-term cost-effectiveness and long-term cost analysis comparing laparoscopic Nissen fundoplication with proton-pump inhibitor maintenance for gastro-oesophageal reflux disease. Br J Surg 2005; 92: 700-706.
10. Epstein D, Bojke L, Sculpher MJ,; REFLUX trial group. Laparoscopic fundoplication compared with medical management for gastro-oesophageal reflux disease: cost effectiveness study. BMJ 2009; 339: b2576.
11. Goeree R, Hopkins R, Marshall JK, Armstrong D, Ungar WJ, Goldsmith C, et al. Cost-utility of laparoscopic Nissen fundoplication versus proton pump inhibitors for chronic and controlled gastroesophageal reflux disease: a 3-year prospective randomized controlled trial and economic evaluation. Value in Health 2011; 14: 263-273.
12. Grant A, Wileman S, Ramsay C, Bojke L, Epstein D, Sculpher M, et al.; REFLUX Trial Group. The effectiveness and cost-effectiveness of minimal access surgery amongst people with gastro-oesophageal reflux disease-a UK collaborative study. The REFLUX trial. Health Technol Assess 2008; 12: 1-181, iii-iv.
13. Romagnuolo J, Meier MA, Sadowski DC,. Medical or surgical therapy for erosive reflux oesophagitis: cost-utility analysis using a Markov model. Ann Surg 2002; 236: 191-202.
14. Roland M, Torgerson DJ,. Understanding controlled trials: what are pragmatic trials? BMJ 1998; 316: 285.
15. Grant A, Cotton SC, Boachie C, Ramsay C, Krukowski Z, Heading RC, et al.; REFLUX Trial Group. Minimal access surgery compared with medical management for gastro-oesophageal reflux disease: five year follow-up of a randomised controlled trial (REFLUX). BMJ 2013; 346: f1908.
16. Organisation for Economic Co-operation and Development. 4.PPPs and Exchange Rates. United Kingdom to Euro Area (17 Countries); 2013. http://stats.oecd.org/Index.aspx?datasetcode=SNA-TABLE4# [accessed 1 April 2013].
17. National Institute for Health and Clinical Excellence (NICE). Guide to the Methods of Technology Appraisal. NICE: London, 2008.
18. Grant A, Boachie C, Cotton SC, Faria R, Bojke L, Epstein D, et al. Clinical and economic evaluation of laparoscopic surgery compared with medical management for gastro-oesophageal reflux disease-five year follow-up of multicentre randomised trial (the REFLUX Trial). Health Technol Assess 2013; (in press).
19. Jenkinson C, Layte R, Wright L, Coulter A,. The UK SF-36: an Analysis and Interpretation Manual. Health Services Research Unit, University of Oxford: Oxford, 1996.
20. Kind P, Dolan P, Gudex C, Williams A,. Variations in population health status: results from a United Kingdom national questionnaire survey. BMJ 1998; 316: 736-741.
21. Billingham LJ, Abrams K, Jones DR,. Methods for the analysis of quality-of-life and survival data in health technology assessment. Health Technol Assess 1999; 3: 1-152.
22. Manca A, Hawkins N, Sculpher MJ,. Estimating mean QALYs in trial-based cost-effectiveness analysis: the importance of controlling for baseline utility. Health Econ 2005; 14: 487-496.
23. Curtis L,. Unit Costs of Health and Social Care. University of Kent, Canterbury: Personal Social Services Research Unit, 2010. http://www.pssru.ac. uk/uc/uc2010contents.htm [accessed 9 May 2012].
24. Department of Health. NHS Reference Costs 2009-2010. Department of Health: London, 2010. http://www.dh.gov.uk/en/Publicationsandstatistics/ Publications/PublicationsPolicyAndGuidance/DH-123459 [accessed 9 May 2012].
25. Electronic Drug Tariff for the National Health Service of England and Wales. Compiled on behalf of the Department of Health: NHS Business Services Authority, NHS Prescription Services, 2010. http://www.ppa.org.uk/edt/December- 2010/mindex.htm [accessed 1 October 2011].
26. White IR, Royston P, Wood AM,. Multiple imputation using chained equations: issues and guidance for practice. Stat Med 2010; 30: 377-399.
27. White IR, Horton NJ, Carpenter J, Pocock SJ,. Strategy for intention to treat analysis in randomised trials with missing outcome Data. BMJ 2011; 342: 910-912.
28. Rubin D., Multiple Imputation for Nonresponse in Surveys. Wiley: New York, 1987.
29. Johannesson M, Weinstein S,. On the decision rules of cost-effectiveness analysis. J Health Econ 1993; 12: 459-467.
30. Briggs A, Gray A,. Handling uncertainty when performing economic evaluation of healthcare interventions. Health Technol Assess 1999; 3: 1-134.
31. White IR, Mander A, Wason J, Bond S,. Handling Missing Outcome Data in Randomised Trials: a Workshop for the Network of Hubs for Trials Methodology Research, Cambridge, 2010.
32. Galmiche JP, Hatlebakk J, Attwood S, Ell C, Fiocca R, Eklund S, et al. Laparoscopic antireflux surgery vs esomeprazole treatment for chronic GERD: the LOTUS randomized clinical trial. JAMA 2011; 305: 1969-1977.
33. Ludemann R, Watson DI, Jamieson GG,. Influence of follow-up methodology and completeness on apparent clinical outcome of fundoplication. Am J Surg 2003; 186: 143-147.
34. Mahon D, Rhodes M, Decadt B, Hindmarsh A, Lowndes R, Beckingham I, et al. Randomized clinical trial of laparoscopic Nissen fundoplication compared with proton-pump inhibitors for treatment of chronic gastro-oesophageal reflux. Br J Surg 2005; 92: 695-699.
35. National Institute for Health and Clinical Excellence (NICE). Dyspepsia: Management of Dyspepsia in Adults in Primary Care. Clinical Guideline 17. NICE: Manchester, 2004. http://publications.nice.org.uk/dyspepsia-cg17 [accessed 9 May 2012].